+86-13031714605
info@millionpharm.com

  • Company
    • About us

    • Partners

    • Value

    • Careers

  • Product
    • Pharmaceutical API

    • Advanced Intermediate

  • R&D&Site
  • News&Events
  • Sustainability
  • Contact Us

PRODUCTS


Home > Products > Advanced Intermediates > Lurasidon intermediates
  • 6-Chloro-5-(2-chloroethyl)oxindole
    6-Chloro-5-(2-chloroethyl)oxindole
  • 37-5;(3aR,7aR)-4'-(1,2-Benzisothiazol-3-yl)octahydrospiro[2H-isoindole-2,1'-piperaziniuM] Methanesulfonate
    37-5;(3aR,7aR)-4'-(1,2-Benzisothiazol-3-yl)octahydrospiro[2H-isoindole-2,1'-piperaziniuM] Methanesulfonate
  • 88-1;3-Piperazinyl-1,2-benzisothiazole hydrochloride
    88-1;3-Piperazinyl-1,2-benzisothiazole hydrochloride
  • 87-0;3-(1-Piperazinyl)-1,2-benzisothiazole
    87-0;3-(1-Piperazinyl)-1,2-benzisothiazole
  • 35-3;(R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane
    35-3;(R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane
  • 05-8;(1r,2r)-1,2-cyclohexanedimethanol
    05-8;(1r,2r)-1,2-cyclohexanedimethanol
  • 29-9;(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione
    29-9;(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione
  • 05-3;(1r,2r)-(-)-1,2-cyclohexanedicarboxylic acid
    05-3;(1r,2r)-(-)-1,2-cyclohexanedicarboxylic acid
  • 19-2;cis-5-norbornene-exo-2,3-dicarboxylic anhydride
    19-2;cis-5-norbornene-exo-2,3-dicarboxylic anhydride
    • 

      Cerebro-cardiovascular

    • 

      Central nervous system

    • 

      Cancer/tumor

    • 

      Anti-diabetics

    • 

      R&D&Pipeline

    • 

      Other APIS

    • 

      Peptides

    • 

      Supplements

    • 

      Sexual Enhancement

    • 

      Apixabn intermediates

    • 

      Bexagliflozin Intermediate

    • 

      Lurasidon intermediates

    • 

      Vortioxeti intermediates

    • 

      Selpercatinib intermediates

    • 

      Indacater intermediates

    • 

      Elacestrant intermediates

    • 

      Repotrectinib/TPX-0005 intermediate

    • 

      Baricitinib Intermediate

    • 

      Ropsacitinib intermediate

    • 

      Other intermediates

    WELCOME

    +86-13031714605
    info@millionpharm.com
    +86-13031714605

    Products

    • Pharmaceutical API

      • Cerebro-cardiovascular

      • Central nervous system

      • Cancer/tumor

      • Anti-diabetics

      • R&D&Pipeline

      • Other APIS

    • Advanced Intermediates

    • Company

      • About us

      • Partners

      • Value

      • Careers

    • R&D&Site

    • News&Events

    • Sustainability

    Contact Us

    Jinan Million Pharmaceutical Co., Ltd

    (Jinan Milin Pharmaceutical Co., Ltd)

    +86-13031714605 (Wechat)
    +86-13031714605
    +86-531-68659554
    info@millionpharm.com
    Room1-2208, Gaoxin district, Jinan, Shandong
     3299907431

    Attention: All products are only for research

    © million | All Rights Reserved

    Leave A Message

    If you are interested in our products and want to know more details, please leave a message here, we will reply you as soon as we can.

    SUBMIT
    
    
    +86-13031714605
    
    WhatsApp
    
    Email
    
    Inquiry
    